Further research involving treatments with pharmacological agents and identification of key proteins involved in these pathways may identify potential targets to safely suppress NFκB and caspase activations in stressed cells without impacting other cellular mechanisms, and can open new windows into potential therapeutic approaches to the treatment of COVID-19 and PD. The gene discussed is NFKB1; the disease is COVID-19.